Emmes

Activities: Drug Delivery

Trending Articles

  1. NHS, MHRA and Medicines UK launch Project Revive to tackle medicine shortages NHS England, the MHRA and Medicines UK have launched Project Revive, a collaborative pilot designed to address critical medicines shortages by fast-tracking dormant...
  2. Isopod Rapid Cleanrooms: the ideal elite controlled environment pod solution for Life Sciences and Engineering start-ups The Guardtech Group’s quick-assembly cleanroom pods combine superior performance, build quality and cost-effectiveness to give new applications the perfect platform to get...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Delivering precision: why advanced therapies are redefining pharmaceutical logistics As advanced therapies narrow tolerances and personalise care, pharmaceutical logistics is being redefined as a precision-driven extension of treatment delivery, writes Michael...
  4. Nose-to-brain delivery outperforms systemic BBB technologies according to MetP Pharma The pioneering company has published preclinical data that strongly supports the advantages of its proprietary nose-to-brain drug delivery technology compared with systemic...
  5. AstraZeneca strengthens weight management pipeline with CSPC Pharmaceuticals collaboration The pair have signed a strategic collaboration covering eight obesity and type 2 diabetes programmes, including a clinical-ready GLP-1/GIP asset, AI-driven peptide discovery...

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual See all

Related Content

Digital

Verdix AI launches clinical trial process optimisation AI/NLP tool

Advantage eClinical Cloud will allow clinicians to optimise the trial planning and building process
Research & Development

Emmes Group and Miimansa AI partner to bring generative AI to clinical research

Emmes will use Miimansa’s modelling tools to process vast amounts of clinical text, as well as allowing for text to text transformations
Research & Development

Emmes and ILiAD Biotechnologies conduct Phase III trials of pertussis vaccine, BPZE1

The global trials will aim to protect patients against Bordetella pertussis infections
Research & Development

Emmes acquires vaccine clinical trials expert VaxTRIALS

The CRO Emmes has announced the acquisition of VaxTRIALS, an organisation who's staff members manage and monitor vaccine clinical trials throughout Latin America
Manufacturing

Emmes recruits new Vice President Matt Honan

Honan served most recently as senior director, M&A and business development, at Quest Diagnostics
Manufacturing

Emmes appoints Ching Tian as Chief Innovation Officer

“I’m very proud to have contributed to the industry’s Decentralised Clinical Trials (DCT) and digital evolution over the past five years"
Manufacturing

Emmes creates cell and gene therapy research

The centre will combine a team of 100 researchers to capitalise on the company’s 35 years of cell and gene therapy experience
Subscribe now